Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.23.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Conversion of Convertible Debt
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Conversion of Convertible Debt
Stockholders’ Accumulated Deficit
Balance, at beginning of period at Dec. 31, 2021 $ 25,212     $ 206,776   $ (181,564)
Balance, at beginning of period (in shares) at Dec. 31, 2021     3,753,132      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options 129     129    
Exercise of stock options (in shares)     18,191      
Vesting of restricted stock units, net of taxes (114)     (114)    
Vesting of restricted stock units, net of taxes (in shares)     13,868      
Stock-based compensation expense 3,878     3,878    
Issuance of stock fair value 851     851    
Shares issued, prepaid advance agreement (in shares)     14,975      
Net income (loss) 23,751         23,751
Balance, at end of period at Sep. 30, 2022 53,707   $ 0 211,520   (157,813)
Balance, at end of period (in shares) at Sep. 30, 2022     3,800,166      
Balance, at beginning of period at Jun. 30, 2022 52,617   $ 0 209,199   (156,582)
Balance, at beginning of period (in shares) at Jun. 30, 2022     3,780,505      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options 6     6    
Exercise of stock options (in shares)     2,941      
Vesting of restricted stock units, net of taxes (6)     (6)    
Vesting of restricted stock units, net of taxes (in shares)     1,745      
Stock-based compensation expense 1,470     1,470    
Issuance of stock fair value 851     851    
Shares issued, prepaid advance agreement (in shares)     14,975      
Net income (loss) (1,231)         (1,231)
Balance, at end of period at Sep. 30, 2022 53,707   $ 0 211,520   (157,813)
Balance, at end of period (in shares) at Sep. 30, 2022     3,800,166      
Balance, at beginning of period at Dec. 31, 2022 54,558   $ 1 220,951   (166,394)
Balance, at beginning of period (in shares) at Dec. 31, 2022     4,492,157      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options $ 10     10    
Exercise of stock options (in shares) 9,502   9,502      
Vesting of restricted stock units, net of taxes $ (14)     (14)    
Vesting of restricted stock units, net of taxes (in shares)     41,020      
Conversion of convertible notes payable 3,404 $ 8,567   3,404 $ 8,567  
Conversion of convertible notes payable (in shares)   1,147,943 904,851      
Canceled due to reverse split (in shares)     (1,957)      
Stock-based compensation expense 4,425     4,425    
Net income (loss) (95,555)         (95,555)
Balance, at end of period at Sep. 30, 2023 (24,605)   $ 1 237,343   (261,949)
Balance, at end of period (in shares) at Sep. 30, 2023     6,593,516      
Balance, at beginning of period at Jun. 30, 2023 22,933   $ 1 234,209   (211,277)
Balance, at beginning of period (in shares) at Jun. 30, 2023     6,144,553      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of restricted stock units, net of taxes 0     0    
Vesting of restricted stock units, net of taxes (in shares)     5,660      
Conversion of convertible notes payable 1,510     1,510    
Conversion of convertible notes payable (in shares)     443,303      
Stock-based compensation expense 1,624     1,624    
Net income (loss) (50,672)         (50,672)
Balance, at end of period at Sep. 30, 2023 $ (24,605)   $ 1 $ 237,343   $ (261,949)
Balance, at end of period (in shares) at Sep. 30, 2023     6,593,516